As one of these blokes who just doesn’t understand how some things work, ie; washing machines, electric irons, and most recently, a little household device which somehow tests a tiny smear of blood, calling into question a recent medical diagnosis of Type 2 Diabetes*. Awe best describes how I feel about the work done by Angle Plc. It’s easy to be impressed with their gadgets.
Just 10 years ago, reporting to “the unit” in hospital for blood tests always was a difficult time.
Firstly (and still unchanged), nursing staff are frustrated lumberjacks, wielding their needles while really wanting a chainsaw. And it’s no less painful when they stab a vein to fill 7 test tubes with blood. Strange to say, what happens next always proved harder to handle, the 90 minute wait while blood is analysed, then a sit-down chat with Mr Consultant. Cancer unit waiting rooms were rarely cheerful places, their very nature producing invisible dark clouds over a bunch of folk, each hoping for the best while dreading the worst.
After perhaps 5 years of tolerating this gloom, a personal decision to “get folk talking” actually worked, usually only needing one outrageous comment to break the ice. For instance, complaining out loud (with a grin) about the frankly terrifying parking in the disabled parking zone, mentioning a blue badge doesn’t mean you have to park like a beginner, always brings out stories from other guests. With the discovery the waiting room didn’t need to be 90 minutes of silent fear, every monthly visit became a personal mission to allow those who wanted to talk, to talk about anything, other than the real reason we were all there.
And then suddenly, it ended.
Telling the ward sister I was popping downstairs for a newspaper and returning 15 minutes later, Mr Consultant was pacing the corridor, waiting. It transpired the lab had a new diagnosis machine, blood work now being produced in minutes. My unread copy of the Daily Mail went straight into a bin, ammunition for my ad hoc comedy sketch no longer required.
*After a diabetes diagnosis, buying the recommended testing machine managed to confirm my blood sugar levels as normal, regardless of the time of day tested. About the only thing I haven’t tried is run a test while actually chewing a sugar cube. The GP practice confirm they shall again test in a few months, just in case we’d an aberration result.
Angle Plc, known for making the Parsortix machine, a device which appears capable of some really clever work in the treatment and diagnosis of various cancers. It’s fairly easy to turn into some sort of fanboy about this sort of thing, after experiencing the horror of prolonged delays for bloodwork results, so perhaps it shall be worth doing some research on their financials from a company value perspective.
From our perspective, there’s something fairly interesting going on. At the start of this year, the share price hit a low of 22.25p, bouncing by around 50% in the period since. After noting the share price Big Picture calculated with an “ultimate bottom” of just 19p, there’s an obvious hope it has bounced before bottom, thus implying some strength may be present. Obviously, from a future perspective, this is a good thing as perhaps expressing an interest in the share may not carry the risk of catching a falling knife.
Currently, above 34p calculates with the potential of a lift to an initial 40p with secondary, if beaten, at a significant 46p.
The chart below describes why 46p risks being significant, giving the share price the opportunity to close above the downtrend from the fall from 160p+ to current levels. We shall need revisit the share price, should it manage to close above the Blue downtrend, due to the future implications potentially being quite positive.
Obviously, a personal bias intrudes in wishing the best for their products but, we do like shares which bounce above their “ultimate bottom” levels.
|Time Issued||Market||Price At Issue||Short Entry||Fast Exit||Slow Exit||Stop||Long Entry||Fast Exit||Slow Exit||Stop||Prior|
23/01/2023 FTSE Closed at 7764 points. Change of -0.08%. Total value traded through LSE was: £ 4,345,074,257 a change of -16.34%
20/01/2023 FTSE Closed at 7770 points. Change of 0.3%. Total value traded through LSE was: £ 5,193,532,558 a change of -8.71%
19/01/2023 FTSE Closed at 7747 points. Change of -1.06%. Total value traded through LSE was: £ 5,688,982,543 a change of 12.09%
18/01/2023 FTSE Closed at 7830 points. Change of -0.27%. Total value traded through LSE was: £ 5,075,315,047 a change of -21.93%
17/01/2023 FTSE Closed at 7851 points. Change of -0.11%. Total value traded through LSE was: £ 6,501,128,630 a change of 48.1%
16/01/2023 FTSE Closed at 7860 points. Change of 0.2%. Total value traded through LSE was: £ 4,389,692,147 a change of -22.72%
13/01/2023 FTSE Closed at 7844 points. Change of 0.64%. Total value traded through LSE was: £ 5,680,414,260 a change of -0.9%
SUCCESS above means both FAST & SLOW targets were met. ‘CESS means just the FAST target met and probably the next time it is exceeded, movement to the SLOW target shall commence.
Our commentary is in two sections. Immediately below are today’s updated comments. If our commentary remains valid, the share can be found in the bottom section which has a RED heading. Hopefully, this will mean you no longer need to flip back through previous reports. HYPERLINKS DISABLED IN THIS VERSION
Please remember, all prices are mid-price (halfway between the Buy and Sell). When we refer to a price CLOSING above a specific level, we are viewing the point where we can regard a trend as changing. Otherwise, we are simply speculating on near term trading targets. Our website is www.trendsandtargets.com.
UPDATE. We often give an initial and a secondary price. If the initial is exceeded, we still expect it to fall back but the next time the initial is bettered, the price should continue to the secondary. The converse it true with price drops.
We can be contacted at firstname.lastname@example.org. Spam filters set to maximum so only legit emails get through…
Section One – Outlook Updated Today. Click here for Section Two – Outlook Remains Valid shares
Click Epic to jump to share: LSE:BBY BALFOUR BEATTY** **LSE:CNA Centrica** **LSE:EMG MAN** **LSE:EZJ EasyJet** **LSE:IAG British Airways** **LSE:IHG Intercontinental Hotels Group** **LSE:LLOY Lloyds Grp.** **LSE:SBRY Sainsbury** **
Updated charts published on : BALFOUR BEATTY, Centrica, MAN, EasyJet, British Airways, Intercontinental Hotels Group, Lloyds Grp., Sainsbury,
LSE:BBY BALFOUR BEATTY. Close Mid-Price: 362.8 Percentage Change: + 0.78% Day High: 364.6 Day Low: 361
Target Met. Now above 365 looks capable of 386 next with secondary, with c ……..
LSE:CNA Centrica. Close Mid-Price: 98.72 Percentage Change: + 0.04% Day High: 99.44 Day Low: 97.62
In the event of Centrica enjoying further trades beyond 100p, the share sh ……..
LSE:EMG MAN. Close Mid-Price: 242.7 Percentage Change: + 1.42% Day High: 242.7 Day Low: 239.1
Further movement against MAN ABOVE 243 should improve acceleration toward ……..
LSE:EZJ EasyJet. Close Mid-Price: 450 Percentage Change: + 0.00% Day High: 457.1 Day Low: 447.2
Target Met. Now above 458 indicates the potential of a lift to 465 next wi ……..
LSE:IAG British Airways Close Mid-Price: 162.38 Percentage Change: -0.28% Day High: 164.08 Day Low: 161.96
Further movement against British Airways ABOVE 165 should now improve acc ……..
LSE:IHG Intercontinental Hotels Group. Close Mid-Price: 5646 Percentage Change: + 0.14% Day High: 5662 Day Low: 5610
Continued trades against IHG with a mid-price ABOVE 5662 should improve th ……..
LSE:LLOY Lloyds Grp.. Close Mid-Price: 49.81 Percentage Change: + 1.09% Day High: 49.79 Day Low: 49.3
This is on the edge of a “safe”, small, near term movement. Above 49.79 in ……..
LSE:SBRY Sainsbury. Close Mid-Price: 244.8 Percentage Change: + 0.58% Day High: 245.9 Day Low: 243
Continued trades against SBRY with a mid-price ABOVE 249 should improve th ……..
*** End of “Updated Today” comments on shares.
This post has already been read 119 times!